Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Prostate. 2012 Apr;72(5):476–486. doi: 10.1002/pros.21450

Table 2.

Number of tags and coverage using variants with call rate ≥ 0.4 by various r2 thresholds by category

MAF ≥ 0.05 r2 ≥ 0.8 r2 ≥ 0.9 r2 ≥ 1.0
category* number of tags coverage (%) number of tags coverage (%) number of tags coverage (%)
HapMap (n=90) 29 81.4 36 76.3 72 56.1
1000 Genome (n=233) 60 98.0 78 97.6 165 96.0
resequence (n=253) 65 100 84 100 175 100
MAF ≥ 0.01 r2 ≥ 0.8 r2 ≥ 0.9 r2 ≥ 1.0
category* number of tags coverage (%) number of tags coverage (%) number of tags coverage (%)
HapMap (n=94) 31 65.1 37 61.2 75 41.3
1000 Genome (n=282) 76 85.5 93 84.9 196 82.1
resequence (n=358) 117 100 136 100 259 100
*

HapMap CEU (release 28) and 1000 Genome CEU (pilot 1 low-coverage data, 10-2010 release) were compared with variants discovered by resequencing Number of matched variants available in each dataset is in parenthesis. 1000 Genome is inclusive of all HapMap reported SNPs